NVS Competitors & Alternatives
Compare Novartis AG ADR with similar stocks in the same industry
Drug Manufacturers - General
NVS
Main Stock$150.93
Tradestie Score
63
Market Cap
$254.99B
P/E Ratio
21.7
Revenue Growth
0.0%
Analyst Upside
+1.9%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$235.18
|
$448.07B | 27.3 | 65 | Compare |
|
ABBV
ABBVIE INC.
|
$222.47
|
$431.71B | 108.6 | 63 | Compare |
|
NVO
Novo-Nordisk A/S
|
$43.55
|
$262.92B | 10.4 | 54 | Compare |
|
AZN
AstraZeneca PLC
|
$178.71
|
$261.56B | 26.9 | 52 | Compare |
|
MRK
Merck & Co., Inc.
|
$115.17
|
$225.13B | 32.4 | 53 | Compare |
|
AMGN
Amgen Inc
|
$347.84
|
$160.70B | 24.4 | 63 | Compare |
|
PFE
Pfizer Inc.
|
$26.04
|
$154.70B | 19.8 | 61 | Compare |
|
GILD
Gilead Sciences Inc
|
$127.23
|
$137.92B | 16.9 | 55 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$44.05
|
$121.27B | 19.1 | 59 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$55.92
|
$96.54B | 15.8 | 61 | Compare |
More NVS Analysis
Data updated: Jun 16, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry